A big question among parents and teachers right now is whether their kids will be vaccinated against COVID-19 in time for the fall school semester. Some have wondered whether the vaccine is even necessary for children. Dr. James Wood, a pediatrician and assistant professor of pediatric infectious diseases, explains what doctors know today about the risk children face of getting and spreading the coronavirus and when vaccines might be available.
Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts
Friday, April 9, 2021
Sunday, February 28, 2021
6 important truths about COVID-19 vaccines
One of the biggest barriers standing in the way of ending the pandemic isn’t medical or logistical. It’s the misinformation about the COVID-19 vaccines.
Demand for vaccine currently exceeds supply, but there are many people who are either unsure whether they should take the vaccine or staunchly against it. This is often because they have heard incorrect information about the vaccine or its effects.
Saturday, May 17, 2014
Harry Stein: Pfizer’s tax-dodging bid for AstraZeneca shows need to tighten U.S. tax rules
American drug maker Pfizer is attempting to acquire AstraZeneca, the United Kingdom’s second-largest pharmaceutical company. If successful, Pfizer would avoid paying billions of dollars in U.S. taxes by becoming a U.K.-based corporation, and Pfizer executives have made these tax benefits a central element of their pitch to AstraZeneca. This corporate maneuver, in which a U.S. corporation becomes a foreign corporation for tax purposes, is called a corporate inversion. Lawmakers on both sides of the aisle have fought back against corporate inversions for years, and they could be stopped if Congress were to strengthen laws passed 10 years ago.
Subscribe to:
Posts (Atom)
